EGFR and non-small cell lung carcinoma: Given that high expression levels of IL17RA in EGFR-mutated LUAD, NSCLC patients treated with EGFR-TKIs with risk allele seem to have higher expression levels of IL17RA, indicating elevated levels of proinflammatory cytokines in NSCLC tissues (61).